Acute Gastroenteritis Clinical Trial
Official title:
Video Discharge Instructions for Pediatric Gastroenteritis in an Emergency Department: a Randomized, Controlled Trial
NCT number | NCT04463355 |
Other study ID # | GEA01 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 1, 2019 |
Est. completion date | June 1, 2020 |
Verified date | July 2020 |
Source | Hospital General Universitario Gregorio Marañon |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Video discharge instructions (VDI) have been suggested as a useful strategy to improve discharge instructions in pediatric emergency units. The goal of this study is to evaluate if the addition of VDI to usual verbal information improved the comprehension of information provided to caregivers of patients who consult for acute gastroenteritis (AGE). An open-label, parallel, randomized trial was designed, enrolling patients who consult for AGE. First, caregivers answer a written test concerning AGE characteristics and management. They are randomly allocated to a control group, which receives verbal discharge instructions, or to an intervention group, which additionally receives video discharge instructions. After discharge, caregivers are contacted by telephone and answer the same test. Main outcome measure is difference between test scores in the first and the second tests, secondary endpoints are how many caregivers score 5/5 on the second test, as well as rate of return visits and caregivers satisfaction with the information received.
Status | Completed |
Enrollment | 139 |
Est. completion date | June 1, 2020 |
Est. primary completion date | March 31, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Month to 16 Years |
Eligibility |
Inclusion Criteria: - Patients who met ESPGHAN criteria for AGE: decreased stool consistency and/or increased evacuation frequency during a period <7 days, associated or not to fever or vomiting. - Patients accompanied by a usual caregiver. Exclusion Criteria: - Patients with severe dehydration - Patients with chronic comorbidities needing special instructions (i.e. neurologic, respiratory or cardiologic) - Patients whose caregivers were not able to communicate in Spanish - Patients who were admitted for hospitalization. |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital General Universitario Gregorio Marañón | Madrid |
Lead Sponsor | Collaborator |
---|---|
Hospital General Universitario Gregorio Marañon |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in test score | We calculated the difference between the score obtained in the initial test and the score obteined in the follow-up test and compared between groups. Scores are based on a 5-question test, minimum score is 0 points and maximum score (best score) is 5 points | From 3 days to 10 days after first emergency care visit | |
Secondary | Number of caregivers getting a total score of 5 points | We measured how many caregivers got a 5-score (perfect) in the follow up test after interventions, and compared between groups | From 3 days to 10 days after first emergency care visit | |
Secondary | Rate of return visits | We asked caregivers whether they had returned to emergency care or to pediatric outpatient clinics for the same problem after the first visit. | 72 hours from from the first emergency care visit | |
Secondary | Satisfaction score with the information received | We asked caregivers to give a score between 1 and 10 (1 very unsatisfied, 10 very satisfied) regarding how useful they felt that the information given to them had been. | From 3 days to 10 days after first emergency care visit |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04682860 -
Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide
|
Phase 4 | |
Recruiting |
NCT03851835 -
Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis
|
Phase 3 | |
Completed |
NCT01577043 -
Efficacy of Racecadotril in Acute Watery Diarrhea in Children
|
Phase 4 | |
Completed |
NCT03234777 -
Evaluating a Knowledge Translation Tool for Parents
|
N/A | |
Not yet recruiting |
NCT02619201 -
Antiemetic Efficacy of Ondansetron Versus Metoclopramide
|
Phase 3 | |
Completed |
NCT02280759 -
Efficacy of Gelatin Tannate in Treatment Acute Gastroenteritis in Children.
|
Phase 1 | |
Completed |
NCT06090708 -
Yogurt Probiotic Bacteria on Relieving Young Children Acute Gastroenteritis
|
N/A | |
Recruiting |
NCT05270291 -
Infectious Etiology of Vomiting in Children With Presumed Acute Gastroenteritis
|
||
Completed |
NCT02025452 -
Novel Diagnostics and Probiotics to Improve Management of Paediatric Acute Gastroenteritis
|
Phase 4 | |
Not yet recruiting |
NCT06038305 -
Prevalence of Anemia and Growth Assessment in Acute Gastroenteritis
|
||
Completed |
NCT02803827 -
Optimizing the Management of Acute Diarrhoeal Disease
|
Phase 3 | |
Completed |
NCT02644200 -
Gelatin Tannate as Treatment for Acute Childhood Gastroenteritis
|
Phase 3 | |
Completed |
NCT02174874 -
Ondansetron Oral Versus Orally Disintegrating Tablets (ODT)
|
N/A | |
Completed |
NCT03539913 -
Efficacy and Safety of Probiotics in the Treatment of Acute Gastroenteritis in Children
|
Phase 4 | |
Recruiting |
NCT06137014 -
Fortified Oral Rehydration Therapy for Pediatric Diarrhea
|
Phase 1/Phase 2 | |
Completed |
NCT04555200 -
Continuous Enteral Rehydration by Nasogastric Tube With ORS in Children With Acute Gastroenteritis
|
||
Completed |
NCT02169817 -
Evaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American Children
|
Phase 4 | |
Unknown status |
NCT02177799 -
Surveillance Study of Acute Gastroenteritis in Hospitalized Children in Rural Area in Lebanon
|
N/A | |
Completed |
NCT01886755 -
Efficacy of an Oral Rehydration Solution Containing the Probiotic Lactobacillus Reuteri Protectis and Zinc in Infants With Acute Gastroenteritis
|
N/A | |
Completed |
NCT01571856 -
Efficacy of Use of Zinc in the Treatment of Acute Diarrhea in Infants
|
Phase 4 |